Legalization of cannabis edibles could be a serious boost to the sector, GMP says

An amendment for inclusion of cannabis edibles and concentrates in Bill C-45 is a positive for the sector, says GMP Securities analyst Martin Landry.

On Tuesday, As part of its clause-by-clause review of Bill C-45, The House Standing Committee on Health (HESA) voted for and passed yesterday an amendment that would ensure edibles containing cannabis and cannabis concentrates become available no later than 12 months following legalization next year. The amendment will be considered and voted on during the third reading of Bill C-45 in the House of Commons.

“This proposed amendment would provide certainty and timing for Canadians and the industry that edibles containing cannabis and cannabis concentrates will be authorized for sale no more than 12 months of the proposed cannabis act,” said Liberal committee member John Oliver.

In a research report to clients Wednesday, Landry said this is a positive development it provides visibility on the timeframe for edibles and concentrates. He believes it could significantly boost the addressable market size.

“HESA’s proposed amendment is quite positive in that it establishes a timeframe for the introduction of edibles and concentrate products, which are expected to comprise an important proportion of the adult-use market in Canada,” the analyst explains. “According to data from BDS analytics, concentrates and edibles accounted for ~40% of the Colorado market in 2016.”

Landry says already established Licesnsed Producer stand to benefit.

“The establishment of a timeframe also provides much welcomed visibility for LPs, allowing for improved business planning around the introduction of these products. We would expect the amendment to provide the ability for LPs to conduct formulation and testing work in order to adequately prepare for the launch of edibles and concentrates which are expected to carry higher profit margins than dried flower products. Assuming approval during the House of Commons’ 3rd reading of bill C-45, the HESA amendment provides us with increased clarity surrounding the potential evolution of the market size in Canada, as well as its composition. Given the expected higher pricing (on gram equivalent basis) associated with edibles and concentrates, the amendment as proposed would have a positive impact on our market size assumptions.”

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Phunware is undervalued, Roth says

Ahead of the company's first quarter results, Roth MKM analyst Darren Aftahi thinks there is money to be made on… [Read More]

24 mins ago

Héroux-Devtek is a buy, Desjardins says

Ahead of the company's quarterly results, Desjardins Securities analyst Benoit Poirier likes what he sees from Héroux-Devtek (Héroux-Devtek Stock Quote,… [Read More]

56 mins ago

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

20 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

22 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

23 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

24 hours ago